Abstract
Ample evidence implicate mitochondria in early brain development. However, to the best of our knowledge, there is only circumstantial data for mitochondria involvement in late brain development occurring through adolescence, a critical period in the pathogenesis of various psychiatric disorders, specifically schizophrenia. In schizophrenia, neurodevelopmental abnormalities and mitochondrial dysfunction has been repeatedly reported. Here we show a causal link between mitochondrial transplantation in adolescence and brain functioning in adulthood. We show that transplantation of allogenic healthy mitochondria into the medial prefrontal cortex of adolescent rats was beneficial in a rat model of schizophrenia, while detrimental in healthy control rats. Specifically, disparate initial changes in mitochondrial function and inflammatory response were associated with opposite long-lasting changes in proteome, neurotransmitter turnover, neuronal sprouting and behavior in adulthood. A similar inverse shift in mitochondrial function was also observed in human lymphoblastoid cells deived from schizophrenia patients and healthy subjects due to the interference of the transplanted mitochondria with their intrinsic mitochondrial state. This study provides fundamental insights into the essential role of adolescent mitochondrial homeostasis in the development of normal functioning adult brain. In addition, it supports a therapeutic potential for mitochondria manipulation in adolescence in disorders with neurodevelopmental and bioenergetic deficits, such as schizophrenia, yet emphasizes the need to monitor individuals’ state including their mitochondrial function and immune response, prior to intervention.
Subject terms: Neuroscience, Molecular biology
Introduction
Mitochondrial function and dynamics are particularly important during early brain neurodevelopment especially in processes of neurogenesis, neuronal differentiation, migration and maturation [1, 2]. In addition, ample evidence highlights the role of mitochondria in mature neurons, in neurite outgrowth, structural plasticity of dendritic spines and neurotransmitter release [3]. Neurons’ reliance on mitochondria is unique by the virtue of their high need for energy and dependence on Ca2+ homeostasis for their activity and survival, two core functions of mitochondria. In addition, mitochondria are major hubs of multiple cellular processes including redox balance maintenance, apoptosis, steroid production and heme biosynthesis. They also provide metabolites that serve as building blocks for macromolecules and modulate epigenetic processes [3]. It is therefore no wonder that mitochondrial impairments are repeatedly evidenced in a variety of neurodevelopmental disorders including Rett syndrome, autism spectrum disorder and schizophrenia (SZ) [4, 5]. In SZ, we and others have demonstrated multiple mitochondria impairments, including structural, genetic, molecular and biochemical deficits, converging at abnormal cellular O2 consumption and ATP production [4, 6, 7].
SZ is conceptualized as a neurodevelopmental disorder, in which symptoms are manifested in early adulthood following subtle prenatal disturbances in brain development that substantially accelerate during adolescence, a period of progressive maturational processes [8]. Abnormalities in neuronal morphology, connectivity and transmission of multiple neural systems have been observed in SZ [9]. 2D and 3D cultures of developing induced pluripotent stem cells (iPSCs) have captured deficits in neurogenesis and neuronal differentiation in the disorder [10, 11]. In-vivo experimental models, such as the maternal immune activation (MIA) models, have significantly added to our understanding of SZ neurodevelopmental-related deficits [2, 12]. Preclinical MIA models have unraveled the effects of the maternal immune response on offspring brain development including impaired neurogenesis, delayed myelination and axonal development, decreased hippocampal and striatal volumes and increased lateral ventricular volume [13]. MIA studies have also demonstrated functional and behavioral changes associated with SZ such as abnormalities in latent inhibition, prepulse inhibition, novel object recognition and increased responses to amphetamine [14]. In addition, mitochondrial dysfunction has been observed in MIA models, including deficits in mitochondria membrane potential (Δψm), enzyme activity, transcript levels of the respiratory complexes’ subunits and mitochondrial morphology [2, 15, 16] turning MIA into an attractive model for studying the link between mitochondria and neurodevelopment. One plausible way to modulate mitochondrial function is by transplantation of healthy mitochondria. During the last decade, it was reported that mitochondria transplantation induces beneficial effects in various pathophysiological conditions associated with mitochondrial dysfunction [15, 17–20]. In the context of the CNS, few studies, including ours, have shown that mitochondria transplantation ameliorated deficits in cognitive and locomotor behaviors in rodent models of neuro-psychiatric disorders such as SZ, Alzheimer’s and Parkinson’s diseases and cerebral ischemia-reperfusion injury [15, 17, 20, 21]. In SZ-derived iPSCs, transplanted mitochondria promoted neuronal differentiation and survival [15].
Taken together, the hitherto data suggest an association between mitochondria and CNS function. Yet, to the best of our knowledge, none of the previous studies shows a mechanism-based causative link between mitochondria and normal adolescent neurodevelopment, in which refining processes of brain structure and circuitry are taking place [22]. Here we provide empirical evidence for a host-dependent reciprocal link between mitochondria and CNS functions in the MIA-SZ model and in healthy control rats, by transplanting healthy mitochondria into the medial prefrontal cortex (mPFC), which parallels the dorsolateral prefrontal cortex, a major dysfunctional site in SZ patients [23, 24]. We show that interfering with host mitochondrial homeostasis, at a critical time-point of cortical development, prevented SZ pathogenesis, yet shifted the normal equilibrium towards abnormality. We demonstrate almost opposite trajectories of change, initiating from altered mitochondrial function and inflammatory response, leading to long-lasting changes in proteome, neurotransmitter turnover, neuronal morphology and ultimately behavior in adult offspring. An inverse shift in mitochondrial function due to interference with their original state was also observed in SZ and healthy subjects-derived lymphoblastoid cell lines (hLCLs) following mitochondria transplantation.
Materials and methods
Detailed description of the study’s Methods is provided in Supplementary Method Section. All samples were coded and analyzed with the experimenter blinded as much as possible to the origin of the samples.
MIA and hLCLs SZ-models
The viral mimic polyinosinic:polycytidylic acid (Poly I:C) MIA model was obtained as described previously [12, 15] (For details see Supplementary Methods). All experimental protocols conformed to the guidelines of the Technion Institution and NIH Institutional Animal Care and Use Committees.
hLCLs were derived from DSM-IV diagnosed SZ patients (11 males, 7 females, average age 40.1 ± 2.5 years old, range 22–61 years) and healthy control (HC) subjects with no prior history of psychiatric illness (12 males, 8 females, average age 42.2 ± 2.2 years old, range 22–60 years). hLCLs were kindly obtained from Prof. Richard P Ebstein, Beer-Sheva Mental Health Center, Israel and from Prof. Peter Zill, Psychiatry Center, Ludwig-Maximilians-University of Munich, Germany. The study was approved by the both Ceneters’ Helsinki Committees. All participants gave a written informed consent. hLCLs were cultured as previously described [25].
Mitochondria isolation and transplantation
Active mitochondria were isolated from naïve rat brains [26] and from SZ and HC-derived hLCLs [25], on a Percoll gradient, the final pellet was suspended in ice-cold 10 mM Tris–HCl buffer (pH 7.4) containing 0.25 M sucrose and 1 mM dehydroascorbic acid (DHA) (vehicle), and their purity, integrity and activity were analyzed as described previously [26].
Intracerebral injection of mitochondria or vehicle was performed in four independent experiments (n = 150 animals, for details see legends to the figures and Supplementary Methods) on PND 34, as described previously [15]. Four experimental groups were obtained: (1) saline and (2) Poly I:C prenatally exposed offspring injected with vehicle (SV and PV, respectively), (3) saline and (4) Poly I:C prenatally exposed offspring transplanted with mitochondria (SM and PM, respectively).
hLCLs were incubated at 37 °C overnight, with vehicle or active mitochondria (50 µg protein/106 cells) isolated from SZ- or HC-hLCLs. The experimental array composed six groups: (1) HC-cells+HC-mitochondria (2) HC-cells+SZ-mitochondria (3) HC-cells+vehicle (4) SZ-cells+HC-mitochondria (5) SZ-cells+SZ-mitochondria (6) SZ-cells+vehicle.
For tracing mitochondria cell entrance, isolated active mitochondria were incubated with 50 nM MitoTracker-Orange CMTMRos dye (Invitrogen, ThermoFisher Scientific) on ice for 20 min followed by two washing steps. Stained mitochondria were intracerebrally injected to Poly I:C and saline offspring and their incorporation into cells was followed 3 h after transplantation by Zeiss LSM880 confocal microscope with X63 Plan Apochromat oil objective. Estimation of mitochondria entrance into cells was assessed by the intensity of cellular MitoTracker-Orange/cell volume using an in-house Python script.
Behavior testing
All tests were conducted during the dark cycle at the following order: social recognition, spontaneous locomotor activity in a novel environment, and amphetamine-induced activity. Behaviors were evaluated in the same animals (6–8 animals/group) in adulthood (PND > 90) when symptoms are fully manifested, using the Ethovision 7 software (Noldus, Wageningen, The Netheralnds).
Social recognition in a novel environment: was evaluated on PND 91–93 as described previously [27]. The test rat was free to explore all three compartments and time spent in each was recorded for 10 min. Social recognition index was calculated as follows: (F-NF)/(F + NF); F = time spent in the chamber with a familiar rat; NF = time spent in the non-familiar empty chamber.
Spontaneous locomotor activity in a novel environment: On PND 100, rats were placed in novel dark boxes (50 cm wide X 70 cm long X 40 cm high) for 30 min during which the distance traveled (cm) by each rat was recorded in 6 min blocks and the distance each rat traveled during 30 min was analyzed.
Amphetamine-induced activity: Immediately after spontaneous locomotor activity test, each of the previous rats was injected with amphetamine (1.0 mg/kg; Sigma-Aldrich, Israel) and replaced into the same experimental boxes and the distance traveled (cm) was recorded in 6 min blocks during 30 min.
Histological and biochemical measurements
Animals were euthanized at three time-points: two (PND 36) and seven (PND 41) days after transplantation, and in adulthood on PND 120, one week after the end of behavioral testing. For immunofluorescence and histochemistry, animals were anesthetized by Ketamine/Xylazine cocktail and intracardially perfused with 4% paraformaldehyde (PFA) or PBS. Brains were immediately dissected, snapped-frozen with liquid nitrogen and stored at −80 °C until use. Coronal brain sections (13 µm thick) including the mPFC and primary motor area (M1: AP 1.7 to 2.7 from bregma) were cut at −25 °C using a cryostat (Leica, Germany). For qRT-PCR, high-pressure liquid chromatography (HPLC) and proteomics, animals were decapitated under anesthesia. The mPFC (AP 2.0 to 3.4; ML 1.1; DV 5 from bregma) was dissected and stored at −80 °C until use.
HPLC
Monoamines’ concentrations were measured on PND 120 in frozen mPFC samples (n = 5–8 animals/group). Norepinephrine (NE), dopamine (DA), its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), serotonin (5-HT) and its metabolite 5-hydroxyindoleacetic acid (5-HIAA) and DA and 5-HT turnover rates were assessed by HPLC with an electrochemical detector and analyzed as described previously [28].
Golgi-Cox staining
On PND 120, animals (n = 4–5 animals/group) were deeply anesthetized with isoflurane, decapitated and their brains immediately dissected and processed using the FD Rapid GolgiStain kit (FD Neurotechnologies, USA) according to the manufacturer’s instructions. Image acquisition, dentrite reconstraction and spine density assessments were done as previously reported [29].
Immunofluorescence
Fixated (4% PFA) and permeabilized (0.5% Triton X-100) mPFC slices were blocked and incubated with primary and secondary antibodies (Supplementary Methods) and then mounted with Dapi Flouromount-G (SouthernBiotech). Slides were scanned using the Zeiss LSM880 confocal microscopy with a x63 Plan-Apochromat oil objective for NeuN and GFAP, or by 3D Histech Pannoramic 250 Flash III slide scanner with a Plan-Apochromat x20 objective connected to an pco.edge 4.2 camera for c-Fos and Iba1 assessments. Nuclei c-Fos+ and cellular Iba1+ were analyzed using in-house Python scripts. c-Fos activation was calculated by nuclei c-Fos total intensity/the total number of Dapi stained nuclei. Microglia density in the mPFC and the adjacent M1 was calculated by the number of Iba1+ cells/tissue area.
Mitochondria functional parameters
Succinate dehydrogenase (SDH) and cytochrome c oxidase (COX) ex-vivo activities were assesses on PND 36 and PND 41 in mPFC frozen sections as described previously [30]. Brain sections were scanned using the above mentioned slide scanner connected to an Adimec Q12A180 camera. Enzyme activity was analyzed using an in-house Python script and calculated by dividing blue SDH or brown COX stain integrated intensity/tissue area.
ROS production was measured on PND 36 and PND 41 in mPFC frozen sections using the redox-sensitive dye 6-carboxy-2’,7’-dichlorodihydrofluorescein diacetate (CM-H2DCFDA) (Invitrogen, USA) as described previously [31]. For autofluorescence, sections were exposed to PBS. Twenty five images were immediately taken by Zeiss Axio Imager Z2 upright microscope (Zeiss, Germany) with x40 EC Plan-Neofluar objective. H2DCFDA puncta were quantified using an in-house Python script. ROS levels were calculated by the number of oxidized H2DCFDA puncta/tissue area.
Mitochondrial basal respiration and its inhibition by DA in hLCLs: Complex I (CoI) driven oxygen consumption rate and its inhibition by DA was measured as described previously [32].
qRT-PCR analysis
RNA was extracted from frozen brain samples of the four experimental groups and naïve Poly I:C and saline offspring and qRT-PCR was performed as described previously [33]. Experimental samples were quantified using the ΔΔCt method against Gapdh, which was not affected by treatment, and against the averaged ΔCt of four saline naïve offspring. Naïve samples were quantified using the ΔCt method against Gapdh. Primers’ data are listed in Supplementary Table 1.
Proteomics and phosphoproteomics
Protein extraction and trypsinization as well as phosphopeptides enrichments of mPFC samples were performed and the resulted peptides were analyzed by LC-MS/MS using a Q-Exactive Plus mass spectrometer (Thermo) fitted with a capillary HPLC (easy nLC1000, Thermo-Fisher). For data analysis and bioinformatics see Supplementary Methods.
Statistics
Results were analyzed for normal distribution by Kolmogorov-Smirnov test. Two groups were compared by a Student’s t-test or paired t-test, multiple comparisons by one-way ANOVA followed by Tukey’s posthoc test or two-way ANOVA followed by simple effect analysis. Linear discriminant analysis (LDA) was done for the cytokine expression. Multivariate correlation matrix was applied and pairwise linear correlation coefficient was assessed by Pearson’s correlation, r ≥ |0.7 | , P ≤ 0.05 was considered significant. Results are expressed as mean ± s.e.m. P ≤ 0.05 was considered statistically significant. GraphPad Prism 9.1.1 and IBM SPSS statistics 24 software were used.
Results
Behavior, neuronal morphology and monoamines alterations in adulthood
Previously we have shown that transplantation of mitochondria into the mPFC in adolescence restores SZ-related selective attention deficit in PM, while provoking attention deficit in SM adult rats [15]. Here we further investigated the spreading of mPFC mitochondrial transplantation effects to various behavior-controlling brain networks. Hence we assessed SZ-related behaviors for which the mPFC, orbitofrontal cortex and the striatum are critical controlling areas [12, 34, 35]. Spontaneous locomotor activity in response to a novel environment, which has been linked with mPFC activity [36], was significantly (P < 0.035) increased in PV as compared to SV rats (Fig. 1a). Mitochondria transplantation reduced this hyperactivity in PM rats to similar levels of SV (PM vs. SV, P < 0.28). In contrast, in SM rats, it led to hyper-locomotion (SM vs. SV, P < 0.05) mirroring PV behavior. Social recognition and amphetamine-induced hyperactivity, primarily linked with orbitofrontal and striatal activities, respectively [37, 38], were not affected by mitochondria transplantation, and were impaired in both Poly I:C groups (Poly I:C vs. saline, P < 0.045 and P < 0.015, respectively) (Supplementary Fig. 1a, b). In line with the behavioral data, a significant (at least P < 0.05) increase in mPFC monoamines NE, HVA, 5-HT levels and in DA turnover was observed in adult PM as compared to the PV group, with NE elevated in comparison with all other groups (at least P < 0.003) (Fig. 1b, c). In SM rats, mitochondria transplantation had no effect on monoamines as compared to SV, yet NE, DOPAC, HVA, 5-HT, 5-HIAA and DA turnover were significantly (at least P < 0.039) decreased as compared to PM rats. No difference was observed between PV and SV rats, supporting previous findings in this model [39]. In the striatum, mitochondria transplantation had no effect on monoamines, including DA, which levels were increased in both PV and PM compared to both saline groups (P < 0.017) (Supplementary Fig. 1c, d). Striatal NE level was below detection threshold.
The behavioral together with the monoamines’ data suggest a localized effect of mitochondria transplantation, and were associated with structural changes in mPFC neurons 90 days post-transplantation (PND 125). In line with the latter, lower distance traveled in a novel environment was significantly correlated with higher quaternary spine density (r = −0.99, P < 0.01), and with lower levels of 5-HT (r = 0.96, P < 0.03) and NE (r = 0.72, P < 0.05) in SV rats. In addition, neuronal morphology showed correlations with mPFC monoamines. Namely, quaternary and quinary dendritic branching were negatively correlated with DA turnover (r = −0.997. P < 0.03) and positively correlated with DA levels (r = 0.908, P < 0.05), respectively. Between groups, significant differences were observed in quaternary (P < 0.007) and quinary (P < 0.044) dendritic branching of layer II/III pyramidal neurons with no significant differences in primary, secondary and tertiary dendrites number (Fig. 1d, e). Specifically, PV exhibited less quaternary dendritic branching (P < 0.008) and quinary branching was almost absent (P < 0.048) as compared to SV rats. Mitochondria transplantation significantly increased the number of both quaternary (P < 0.002) and quinary (P < 0.015) branching in PM as compared to PV rats, yet in SM decreased the number of quaternary (P < 0.043) dendrites as compared to SV rats. Enriched neuronal branching in PM was associated with a significant increase in quaternary dendrites spine density as compared to PV (P < 0.0002), which exhibited lower quaternary spine density as compared to all other groups (at least P < 0.008 for all comparisons) (Fig. 1d, f). SM quaternary spine density was not different from that of SV and PM. No difference was observed in branching and spine density of secondary and tertiary dendrites.
Alterations in proteome and phosphoproteome in adulthood
Next, we studied proteome and phosphoproteome, possibly underlying the behavioral and neuronal changes induced by transplanted mitochondria. A total of 3647 proteins and 4803 phosphorylated proteins (FDR < 0.01) were identified. Unsupervised hierarchical clustering of the significantly different proteins (n = 153) and protein phospho-sites (n = 419) distinguished between the four experimental groups and indicated the highest dissimilarity between SV and PV groups (Fig. 2a, b). Notably, a high similarity of proteome profile was observed between SV and PM, while that of SM was more similar to PV than to SV. Specifically, protein expression in the major metabolic processes cluster (C2) was increased in SV and PM, while decreased in PV and SM (Fig. 2a, c). In the phosphoproteome profile, the most profound differences between groups were observed in neuronal projection development (pC2) and cytoskeleton organization in neuronal extension (pC4) clusters (Fig. 2b, c), with PM showing the highest, while PV the lowest phosphorylation events in pC2 and pC4 clusters, respectively.
Pathway enrichment analysis of the significantly different proteins and phosphosites identified carbon metabolic pathways in the proteome (n = 30 proteins), while neuron synapse and post-synaptic signaling pathways (n = 52 phosphoproteins) in the phosphoproteome (Fig. 2d, e). Significant bi-weight mid-correlations (r > |0.5 | , P ≤ 0.05) were observed between 90% of the significantly different metabolic proteins and 1–3 phospho-modules out of five eigenprotein modules obtained by Weighted Correlation Network Analysis (WGCNA) (Fig. 2f, g), suggesting that alterations in neuronal function and development are closely linked with carbon metabolic pathways.
Deregulations mainly in energy metabolism and neuronal function-related pathways were also identified upon analyzing the following comparisons: PV vs. SV; PM vs. PV; PM vs. SV; SM vs. SV groups by Ingenuity Pathway Analysis (IPA) (Fig. 2h–k and Supplementary Tables 2 and 3). Pathways reaching inhibition/activation prediction (−2 > z-score>2) in the proteome and phosphoproteome analyses were mostly inhibited in PV vs. SV (sirtuin, netrin, integrin, IGF-1, Gβγ, Erk/MAPK, Wnt/β-catenin and semaphorin neuronal-repulsive pathways) (Fig. 2h), while activated in PM vs. PV (ephrin receptor, integrin, IGF-1 and Gβγ, synaptogenesis, reelin, LTP, Erk/MAPK, pyridoxal 5’-phosphate salvage, insulin secretion and pyrimidine ribonucleotides salvage pathways) (Fig. 2i). An interesting exception in PV vs. SV comparison was the activation of ferroptosis signaling, associated with deleterious ROS accumulation [40].
SM vs. SV comparison showed inhibition of gluconeogenesis, which correlates with enhanced glycolysis and mitochondrial deficits [41], and of semaphorin neuronal-repulsive signaling pathways, while activation of dopamine-DARPP32 feedback in cAMP signaling (Fig. 2j), possibly leading to an imbalance in dopaminergic, glutamatergic and GABAergic cellular signaling [42]. In PM vs. SV comparison, transplantation led to inhibition of apoptosis signaling, yet activation of various pathways vital for neural circuities, neurotransmission and synaptic plasticity (synaptogenesis, Ca2+, Gβγ, ErbB2-ErbB3, PLP salvage, VEGF, NGF, and Neurotrophin/TRK pathways) [43–45] (Fig. 2k). These hyper-shifted changes in PM may be required in order to reach recovery from the abnormal pattern. Puzzlingly, eIF2 signaling, essential for protein synthesis and affected by various stressors, was inhibited. In both PM and SM vs. SV, HIF-1α signaling, a major pathway in the hypoxia-ischemia response, which has been implicated in SZ [46–48], was inhibited (Fig. 2j, k), suggesting a long-lasting effect of mitochondrial transplantation on the modulation of oxygen saturation.
To identify global proteomics trends between the groups, proteins and phosphoproteins were analyzed for pathway enrichment (Fig. 2l, m and Supplementary Tables 4 and 5). Proteome data clustered into six core functions; neuronal processes, energy metabolism, cellular stress regulation, intracellular signaling, transcription-translation and protein regulation (Fig. 2l). Phosphoproteome clustered into similar five core functions; neuronal processes, energy metabolism, cellular stress response, intracellular signaling and RNA/DNA/protein processing (Fig. 2m). The differentially enriched pathways in the proteome were predominantly observed in PM vs. PV and PM vs. SV comparisons across all core functions, whereas in phosphoproteome in SM vs. SV and PV vs. SV. More specifically, according to proteome Normalized Enrichment Scores (NES) scores (Supplementary Table 4), mitochondria transplantation to Poly I:C rats caused an upregulation of pathways in all six core functions compared to PV. However, compared to SV, a more complex effect was observed, as intracellular signaling, neuronal processes and energy metabolism core functions were upregulated, while protein regulation, transcription-translation and cellular stress regulation were downregulated in PM, suggesting a new equilibrium state in PM mPFC enabling the restoration of behavioral response and neuronal outgrowth. In the phosphoproteome analysis, enrichments indicated an alteration in phosphorylation status leading to either activation or inhibition of the pathways composing the core functions. Upregulated phosphorylation in SM was observed in all core functions except for energy metabolism as compared to SV, whereas in PV alteration across core functions was inconsistent as compared to SV, with an increase, no change or decrease (Supplementary Table 5). In all, these data further suggest a disparate global effect of mitochondrial transplantation depending on disease/health state.
Acute effects of mitochondria transplantation in adolescence
We next studied the acute changes induced by mitochondria transplantation, which may instigate their long-term effects. We studied markers of three intevowen processes, mitochondria function, immune response, and neuronal activity. First, we followed entrance efficiency of MitoTracker-orange labeled mitochondria into mPFC neurons, astrocytes and microglia (Fig. 3a–d). Three hours post-transplantation, labeled mitochondria preferentially entered neurons both in Poly I:C and saline rats. Few mitochondria were identified inside astrocytic processes, and almost none in microglia. The latter might be due to either mitochondria disability to enter or their instant degradation by microglia. There was no significant difference in labeled-mitochondria entrance into neurons between PM and SM (300.8 ± 24.4 and 267.7 ± 52.6 intensity/volume).
Mitochondria entrance into neurons was associated with increased expression of c-Fos, an early functional marker for neural activation [49], in PM as compared to PV rats (PM vs. PV, P < 0.026; PV vs. SV, P < 0.031), reaching SV levels two days after transplantation (Fig. 3e, f). However, in SM rats, c-Fos was not affected. Seven days after transplantation c-Fos activation was similar in all groups (Supplementary Fig. 2a).
Next, we studied mPFC ex-vivo activity of COX (complex IV) of the electron-transfer-chain (ETC), and of SDH, participating both in mitochondrial tri-citric acid cycle and in ETC (complex II) (Fig. 4a–c and Supplementary Fig. 2b–d) both implicated in SZ [50, 51]. COX activity was significantly increased two days after transplantation in PM as compared to all other groups (P < 0.0001) with no significant difference between groups seven days later. SDH activity was not affected at both time-points. ROS, which are implicated in SZ [52, 53], are primarily produced by mitochondria, considered as signal mediators, and involved in cell growth, differentiation, progression and death [54, 55]. Consistent with the literature [2], an increase in the ROS indicator, oxidized H2DCFDA, was evidenced in PV as compared to the SV group two and seven days following surgery (P < 0.048 and P < 0.039, respectively) (Fig. 4d–g). Mitochondria transplantation significantly decreased ROS in PM rats as compared to PV (P < 0.045) restoring it to normal levels already at two days, which lasted for at least seven days following transplantation (PM vs. PV, P < 0.038). In the SM group, however, ROS massively increased seven days after surgery (SM vs. SV or PM, P < 0.006).
There is a well-established interplay between mitochondria and the immune system. We therefore studied the effect of transplanted mitochondria on mPFC inflammatory response. We assessed transcripts’ level of pro-inflammatory TNF-α, IL-1β, IL-6, anti-inflammatory IL-10, TGF-β cytokines, the chemokine CX3CL1 and its receptor CX3CR1, both indicators of neuron-microglia crosstalk, and calculated TNF-α/IL-10 ratio, an index of immune homeostasis (Supplementary Fig. 2e, f). First, we assessed cytokine transcripts in naïve Poly I:C and saline offspring rats in adolescence. We observed a significant reduction in IL-10 (P < 0.043), an increase in CX3CL1 (P < 0.0008) and a significantly higher TNF-α/IL-10 ratio in Poly I:C as compared to saline offspring (P < 0.003) (Fig. 4h), indicating an imbalance between major pro- to anti-inflammatory cytokines in Poly I:C offspring. Following transplantation, significant canonical discrimination of the immune profile between groups was obtained by LDA at two and seven days post-procedure (2 days: PF1 < 0.031, 88% between-group variability; 7 days: PF1 < 0.002 and PF2 < 0.015 with 86.7% and 81.9% between-group variability for all predictors, respectively) (Fig. 4i, k). At two days, all groups’ immune profile centroids±2σ were more converged than at seven days, suggesting predominance of surgical procedure in the immune response at two days, which declined at the later time point. Further analysis of the structure matrix revealed TNF-α/IL-10 ratio (Wilk’s λ = 0.518) as the significant predictor with 93.8% corrected group classification at two days (Fig. 4j), and IL-1β (Wilk’s λ = 0.675) and CX3CL1 (Wilk’s λ = 0.554) with 100% corrected group classification at seven days after transplantation (Fig. 4l, m). TNF-α/IL-10 ratio in PM group, reached SV values, while those of PV and SM were significantly lower from both SV (P < 0.021 and P < 0.035, respectively) and PM (P < 0.012 and P < 0.02, respectively), suggesting impaired immune response balance in PV and SM rats, which was restored in PM rats. IL-1β was significantly increased in all groups as compared to SV (at least P < 0.01), yet CX3CL1 was significantly increased in SM as compared to all other groups (at least P < 0.041), suggesting neuronal immune-stress in SM group is similar to that observed in the naïve Poly I:C group. Concomitantly, Iba1+ microglia, the CNS immune-residents, showed infiltration into the mPFC compared to their density in adjacent M1 cortical area in all groups two days after surgery (paired Student’s t-test, P < at least 0.04) (Fig. 4n–p and Supplementary Fig. 2g, h). Iba1+ microglia declined at seven days in all groups except for the PM group as compared to SV (P < 0.036). Interestingly, Iba1+ microglia density was negatively correlated with TGF-β (r = −0.973, P < 0.03) at seven days, while at two days with TNF-α/IL-10 ratio (r = −0.913, P < 0.05) in the PM group.
The inverse effect of mitochondria transplantation in hLCLs
Previously we have shown that mitochondrial respiration, as well as the extent of its inhibition by DA, are impaired in SZ-derived cells, and transplantation of HC-derived mitochondria restored both to normal levels [15, 25]. These findings were repeated using different hLCLs (basal respiration and its inhibition by DA, P < 0.009 and P < 0.049, SZ-hLCLs+HC-Mit vs. SZ-hLCLs, respectively) (Fig. 5a, b). However, transplantation of HC-derived mitochondria into HC-hLCLs significantly reduced basal respiration to SZ-hLCLs levels (HC-hLCLs+HC-Mit vs. HC-hLCLs, P < 0.007). Transplantation of SZ-derived mitochondria impaired both parameters in HC-hLCLs mimicking SZ-hLCLs pattern (basal respiration and its inhibition by DA, HC-hLCLs+SZ-Mit vs. HC-hLCLs, P < 0.002 and P < 0.0001, respectively), but did not further impair SZ-hLCLs. These data substantiate cells- and mitochondria origin-dependent beneficial/detrimental effects in hLCLs, which have been repeatedly used as a “neuronal proxy” to explore biological mechanisms of psychiatric disorders.
Discussion
The present data demonstrate that mitochondria are crucial factors in determining the trajectory of late brain development and thereby behavior. We showed that a single transplantation of isolated healthy mitochondria in adolescence into the rat mPFC led to an opposite pattern of change in behavior and neuronal function in adulthood depending on host state, namely beneficial in the neurodevelopmental MIA model of SZ, yet detrimental in normal rats. Such an opposite pattern initiated shortly after transplantation, during which exogenous mitochondria interfered with mitochondrial COX activity, ROS and the immune response. The similar pattern of change in adolescence and adulthood in both Poly I:C and saline offspring suggests that interference with host-state during late developmental stages of the prefrontal cortex contributes to the long-term consequences.
Long-term opposite outcomes of mitochondria transplantation were manifested at the level of mPFC-regulated behavior, neuronal structure and transmission and intracellular processes. Our previous study showed that mitochondrial state was affected, as mitochondrial Δψm, the driving force for ATP production, was restored to normal in Poly I:C but impaired in control adult rats by the transplantation [15].The effect of mPFC mitochondria transplantation on behavior was probably restricted to the region of intervention as behaviors involving activation of the mPFC, latent inhibition [15] and locomotor agitation in a novel environment, were altered, while social recognition and amphetamine-induced activity, for which activation of the orbitofrontal cortex and striatum, respectively, is critical [37, 38], were not affected. Behavioral improvements in PM were associated with enhanced monoamines’ transmission solely in the mPFC, as well as normalization of pyramidal neurite outgrowth and dendritic spine density. However, in SM rats, the deleterious behavioral outcome was associated with no change in monoamines’ transmission, and impaired neuronal sprouting. Proteomics and phosphoproteomics provided several insights regarding the intracellular pathways that possibly underlie the substantial recovery and deterioration in PM and SM, respectively. Considering the limited knowledge regarding the downstream outcome of numerous phosphorylation sites and that most of the relevant tools cannot take into account multiple phosphorylated sites of a given protein simultaneously, the information that could be driven from phosphoproteomics is partial. Regardless, by various types of data analyses, we detected differences between groups that predominantly converged into two intracellular pathways, neuronal multifaceted functions and morphology, and energy metabolism. WGCNA showed a close link between the significantly differentiated metabolic and neuronal processes. The PM proteome and phosphoproteome profiles showed a considerable similarity to SV rats with by-and-large activation (vs. PV) of multiple intracellular pathways regulating neuronal activity and vitality (e.g. synaptogenesis, LTP and ERK/MAPK signaling pathways) and metabolic processes (e.g. carbohydrate glucose homeostasis, fatty acid metabolism and mitochondrial processes). However, the SM group showed a resemblance to PV rats, mainly observed by its shift towards PV in proteome profile and in the phosphoproteome core functions enrichment, including neuronal processes and energy metabolism. In all, the altered proteome profiles possibly underlie the upstream improvements or impairments in neuronal function and behavior. Indeed, a large body of proteomic evidence in SZ has identified consistent disruption mainly in neuronal transmission, synaptic plasticity, neurites outgrowth, cytoskeleton arrangement, calcium signaling, oxidative stress and energy metabolism [6, 56, 57].
The long-term change was evoked by a preferential entrance of exogenous mitochondria into neurons, equally into both Poly I:C and saline rats. The latter is supported by our findings in SZ and HC-derived hLCLs, in which isolated mitochondria enter cells with the same efficiency regardless of donor or host origins (unpublished data). It is not clear why mitochondria preferentially entered neurons rather than astrocytes or microglia, except for neurons’ exceptional high-energy demands. Indeed, neurons in need incorporate functional mitochondria released by astrocytes [54].
Mitochondria are essential for neuronal proper functioning yet also for oxidative stress-mediated cellular damage, with ROS playing an important role in both. Notably, it has been reported that an altered redox state is involved in the regulation of various transcription factors and protein activators thereby modulating signaling pathways as well as dendritic length and spine density in neurons [55, 58]. In addition, ample evidence shows that mitochondria, their mtDNA and ROS are heavily involved in inflammation induction [59]. On the other hand, the production of pro-inflammatory mediators, such as TNF-α and IL-1β, impairs mitochondrial function by increasing ROS and decreasing respiratory complexes activity and ATP production [60]. These interacting processes, all implicated in SZ [4, 6, 52, 61], were differentially modulated in PM and SM rats shortly after mitochondrial transplantation. In PM rats, mitochondria transplantation induced an early activation of neurons (assessed by c-Fos), improvement in mitochondrial functions indicated by normalization of ROS production and a temporary increase in COX activity as well as restoration of the immune balance (expressed by TNF-α/IL10 ratio). In SM rats, however, transplantation had no effect on neuronal early activation, caused a massive increase in ROS, induced an early immune imbalance and a later increase in the neuronal secreted stress chemokine CX3CL1. Interestingly, only in PM rats, mPFC microglia increased density persisted seven days after surgery, whilst cytokines’ levels were attenuated, suggesting the involvement of microglia in synaptic re-organization, facilitating synaptic plasticity and remodeling neuronal network [62]. The mechanism by which mitochondria induce long-term effects is still elusive. It is reasonable to assume that exogenous mitochondria do not last long in brain, as the majority of mitochondrial proteins are encoded by the nDNA and endogenous mitochondria turnover rate in brain is maximally 25 days [63]. It is also not likely that mtDNA is responsible for the long-term effects as our in-vitro findings showed that donor mitochondrial DNA could not be detected in host cells 10 days after transplantation, whereas their effect on respiration lasted for >28 days [15] (and unpublished data). Regardless, our study shows that the outcome of interference is highly dependent on host physiological conditions such as the immune system, oxidative state and bioenergetics.
This study suggests a causal link between mitochondria inherent state and adolescent brain development. Still, several questions remain open. For example, the importance of transplantation timing for the long-term outcomes; which inherent processes mediate mitochondrial transplantation-induced effects; how mitochondria-instigated acute effects lead to the long-term consequences; how exogenous mitochondria interfere with host-specific mitochondrial homeostasis; and how/whether mitochondrial transplantation-induced changes in the mPFC project to additional PFC subregions or to other brain regions implicated in late stages of brain development and/or in SZ. In this study, CoI activity was not assessed despite its major role in the pathophysiology of SZ [4, 50]. To the best of our knowledge there is no histochemical assay for CoI, probably since its substrate NADH is metabolized by additional cellular dehydrogenases. The reliable and reproducible enzymatic or in-gel activity assessments in isolated mitochondria [26, 64] were also not applicable due to the mPFC size. Finally, the relevance to SZ of the host-dependent opposite effects of transplantation in rats was demonstrated in SZ and healthy subjects-derived hLCLs, which showed donor- and host- dependent inverse shift in mitochondrial function due to the interference with their original state. hLCLs have been shown to retain many SZ-related abnormalities including those of mitochondria and are suggested as a medication-free peripheral cell model for the disorder. Further studies are warranted to explore the mechanism of interaction between transplanted and host mitochondria depending on their health/disease origin in CNS-relevant culture models. Regardless, the present study supports the potential of mitochondria manipulation as a novel treatment for disorders with neurodevelopmental and bioenergetic deficits, such as SZ. In addition, it emphasizes the need to consider possible detrimental effects induced by the two-edge sword nature of mitochondria and their possible interaction with subject’s physiological status, pharmacotherapy, immunological and mitochondrial inherent state. In this respect, it is notable that beneficial/detrimental effects of mitochondrial transplantation in SZ/healthy subjects-derived hLCLs were depended on both donor mitochondria origin and host mitochondrial state.
Supplementary information is available at MP’s website.
Supplementary information
Acknowledgements
This study was supported by grants from the Israel Science Foundation (ISF) (1517/15) and Russell Berrie Nanotechnology Institute, Technion (2021273). The authors thank Ariel Shemesh, PhD from The Image Processing Unit and Ronit Hod, PhD from The Genomics Unit of The Biomedical Core Facility at the Rappaport Faculty of Medicine, Technion, for data analysis services. The authors thank The Smoler Protein Research Center, Faculty of Biology, Technion, for LC-MS/MS proteome and phosphoproteome analyses.
Author contributions
Designed experiments and analyses: HME and DBS. Animal procedures: HME with the help of DF and DBS. Molecular biology and HPLC experiments: HME and RK. Immunofluorescence, imaging and imaging analysis: HME. Bioinformatics: HME. Data visualization and curation: HME with the help of all authors. Wrote the first draft of the paper: HME with the help of all authors. Critically revised the manuscript: DBS and DF. Conceived the study, acquired Funding and supervised the work: DBS.
Competing interests
The authors declare no competing interests.
Footnotes
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
The online version contains supplementary material available at 10.1038/s41380-022-01865-4.
References
- 1.Fame RM, Lehtinen MK Mitochondria in Early Forebrain Development: From Neurulation to Mid-Corticogenesis. Front Cell Dev Biol. 2021;9. 10.3389/fcell.2021.780207 [DOI] [PMC free article] [PubMed]
- 2.Gyllenhammer LE, Rasmussen JM, Bertele N, Halbing A, Entringer S, Wadhwa PD, et al. Maternal inflammation during pregnancy and offspring brain development: the role of mitochondria. Biol Psychiatry Cogn Neurosci Neuroimaging. Published online November 2021. 10.1016/j.bpsc.2021.11.003 [DOI] [PMC free article] [PubMed]
- 3.Kann O, Kovács R. Mitochondria and neuronal activity. Am J Physiol-Cell Physiol. 2007;292:C641–C657. doi: 10.1152/ajpcell.00222.2006. [DOI] [PubMed] [Google Scholar]
- 4.Ben-Shachar D. Mitochondrial multifaceted dysfunction in schizophrenia; complex I as a possible pathological target. Schizophr Res. 2017;187:3–10. doi: 10.1016/j.schres.2016.10.022. [DOI] [PubMed] [Google Scholar]
- 5.Norat P, Soldozy S, Sokolowski JD, Gorick CM, Kumar JS, Chae Y, et al. Mitochondrial dysfunction in neurological disorders: exploring mitochondrial transplantation. NPJ Regen Med. 2020;5:1–9. doi: 10.1038/s41536-020-00107-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JJ, Griffin JL, et al. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry. 2004;9:684–97. doi: 10.1038/sj.mp.4001511. [DOI] [PubMed] [Google Scholar]
- 7.Gonçalves VF, Cappi C, Hagen CM, Sequeira A, Vawter MP, Derkach A, et al. A comprehensive analysis of nuclear-encoded mitochondrial genes in schizophrenia. Biol Psychiatry. 2018;83:780–9. doi: 10.1016/j.biopsych.2018.02.1175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Fatemi SH, Folsom TD. The neurodevelopmental hypothesis of schizophrenia, revisited. Schizophr Bull. 2009;35:528–48. doi: 10.1093/schbul/sbn187. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Stephan KE, Friston KJ, Frith CD. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull. 2009;35:509–27. doi: 10.1093/schbul/sbn176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Robicsek O, Karry R, Petit I, Salman-Kesner N, Müller FJ, Klein E, et al. Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients. Mol Psychiatry. 2013;18:1067–76. doi: 10.1038/mp.2013.67. [DOI] [PubMed] [Google Scholar]
- 11.Notaras M, Lodhi A, Dündar F, Collier P, Sayles NM, Tilgner H, et al. Schizophrenia is defined by cell-specific neuropathology and multiple neurodevelopmental mechanisms in patient-derived cerebral organoids. Mol Psychiatry. Published online November, 2021. 10.1038/s41380-021-01316-6 [DOI] [PMC free article] [PubMed]
- 12.Zuckerman L, Rehavi M, Nachman R, Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology. 2003;28:1778–89. doi: 10.1038/sj.npp.1300248. [DOI] [PubMed] [Google Scholar]
- 13.Liu YH, Lai WS, Tsay HJ, Wang TW, Yu JY. Effects of maternal immune activation on adult neurogenesis in the subventricular zone–olfactory bulb pathway and olfactory discrimination. Schizophr Res. 2013;151:1–11. doi: 10.1016/j.schres.2013.09.007. [DOI] [PubMed] [Google Scholar]
- 14.Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun. 2010;24:881–97. doi: 10.1016/j.bbi.2010.03.005. [DOI] [PubMed] [Google Scholar]
- 15.Robicsek O, Ene HM, Karry R, Ytzhaki O, Asor E, McPhie D, et al. Isolated mitochondria transfer improves neuronal differentiation of schizophrenia-derived induced pluripotent stem cells and rescues deficits in a rat model of the disorder. Schizophr Bull. 2018;44:432–42. doi: 10.1093/schbul/sbx077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Ifhar LS, Ene HM, Ben-Shachar D. Impaired heme metabolism in schizophrenia-derived cell lines and in a rat model of the disorder: Possible involvement of mitochondrial complex I. Eur Neuropsychopharmacol. 2019;29:577–89. doi: 10.1016/j.euroneuro.2019.03.011. [DOI] [PubMed] [Google Scholar]
- 17.Chang JC, Wu SL, Liu KH, Chen YH, Chuang CS, Cheng FC, et al. Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson’s disease: Restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity. Transl Res. 2016;170:40–56.e3. doi: 10.1016/j.trsl.2015.12.003. [DOI] [PubMed] [Google Scholar]
- 18.Emani SM, Piekarski BL, Harrild D, del Nido PJ, McCully JD. Autologous mitochondrial transplantation for dysfunction after ischemia-reperfusion injury. J Thorac Cardiovascular Surg. 2017;154:286–9. doi: 10.1016/j.jtcvs.2017.02.018. [DOI] [PubMed] [Google Scholar]
- 19.Huang PJ, Kuo CC, Lee HC, Shen CI, Cheng FC, Wu SF, et al. Transferring xenogenic mitochondria provides neural protection against ischemic stress in ischemic rat brains. Cell Transpl. 2016;25:913–27. doi: 10.3727/096368915X689785. [DOI] [PubMed] [Google Scholar]
- 20.Nitzan K, Benhamron S, Valitsky M, Kesner EE, Lichtenstein M, Ben-Zvi A, et al. Mitochondrial transfer ameliorates cognitive deficits, neuronal loss, and gliosis in Alzheimer’s disease mice. J Alzheimers Dis. 2019;72:587–604. doi: 10.3233/JAD-190853. [DOI] [PubMed] [Google Scholar]
- 21.Zhang Z, Ma Z, Yan C, Pu K, Wu M, Bai J, et al. Muscle-derived autologous mitochondrial transplantation: a novel strategy for treating cerebral ischemic injury. Behavioural Brain Res. 2019;356:322–31. doi: 10.1016/j.bbr.2018.09.005. [DOI] [PubMed] [Google Scholar]
- 22.Casey BJ, Getz S, Galvan A. The adolescent brain. Developmental Rev. 2008;28:62–77. doi: 10.1016/j.dr.2007.08.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Potkin SG, Turner JA, Brown GG, McCarthy G, Greve DN, Glover GH, et al. Working memory and DLPFC inefficiency in schizophrenia: the FBIRN study. Schizophr Bull. 2009;35:19–31. doi: 10.1093/schbul/sbn162. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Konopaske GT, Lange N, Coyle JT, Benes FM. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry. 2014;71:1323. doi: 10.1001/jamapsychiatry.2014.1582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Rosenfeld M, Brenner-Lavie H, Ari SGB, Kavushansky A, Ben-Shachar D. Perturbation in mitochondrial network dynamics and in complex I dependent cellular respiration in schizophrenia. Biol Psychiatry. 2011;69:980–8. doi: 10.1016/j.biopsych.2011.01.010. [DOI] [PubMed] [Google Scholar]
- 26.Brenner-Lavie H, Klein E, Zuk R, Gazawi H, Ljubuncic P, Ben-Shachar D. Dopamine modulates mitochondrial function in viable SH-SY5Y cells possibly via its interaction with complex I: Relevance to dopamine pathology in schizophrenia. Biochim Biophys Acta Bioenerg. 2008;1777:173–85. doi: 10.1016/j.bbabio.2007.10.006. [DOI] [PubMed] [Google Scholar]
- 27.Nadler JJ, Moy SS, Dold G, Trang D, Simmons N, Perez A, et al. Automated apparatus for quantitation of social approach behaviors in mice. Genes Brain Behav. 2004;3:303–14. doi: 10.1111/j.1601-183X.2004.00071.x. [DOI] [PubMed] [Google Scholar]
- 28.Yaniv SP, Lucki A, Klein E, Ben-Shachar D. Dexamethasone enhances the norepinephrine-induced ERK/MAPK intracellular pathway possibly via dysregulation of the α2-adrenergic receptor: Implications for antidepressant drug mechanism of action. Eur J Cell Biol. 2010;89:712–22. doi: 10.1016/j.ejcb.2010.05.002. [DOI] [PubMed] [Google Scholar]
- 29.Radley JJ, Sisti HM, Hao J, Rocher AB, McCall T, Hof PR, et al. Chronic behavioral stress induces apical dendritic reorganization in pyramidal neurons of the medial prefrontal cortex. Neuroscience. 2004;125:1–6. doi: 10.1016/j.neuroscience.2004.01.006. [DOI] [PubMed] [Google Scholar]
- 30.Franco-Iborra S, Tanji K. Histochemical and immunohistochemical staining methods to visualize mitochondrial proteins and activity. Methods Cell Biol. 2020;155:247–70. doi: 10.1016/bs.mcb.2019.11.024. [DOI] [PubMed] [Google Scholar]
- 31.Wilhelm J, Vytášek R, Uhlík J, Vajner L. Oxidative stress in the developing rat brain due to production of reactive oxygen and nitrogen species. Oxid Med Cell Longev. 2016;2016. 10.1155/2016/5057610 [DOI] [PMC free article] [PubMed]
- 32.Brenner-Lavie H, Klein E, Ben-Shachar D. Mitochondrial complex I as a novel target for intraneuronal DA: Modulation of respiration in intact cells. Biochem Pharm. 2009;78:85–95. doi: 10.1016/j.bcp.2009.03.024. [DOI] [PubMed] [Google Scholar]
- 33.Ben-Shachar D, Karry R. Neuroanatomical pattern of mitochondrial complex I pathology varies between schizophrenia, bipolar disorder and major depression. PLoS One. 2008;3:e3676. doi: 10.1371/journal.pone.0003676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Osborne AL, Solowij N, Babic I, Huang XF, Weston-Green K. Improved social interaction, recognition and working memory with cannabidiol treatment in a prenatal infection (poly I:C) rat model. Neuropsychopharmacology. 2017;42:1447–57. doi: 10.1038/npp.2017.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Lipska BK, Weinberger DR. To model a psychiatric disorder in animals: Schizophrenia as a reality test. Neuropsychopharmacology. 2000;23:223–39. doi: 10.1016/S0893-133X(00)00137-8. [DOI] [PubMed] [Google Scholar]
- 36.Kolb B. Functions of the frontal cortex of the rat: a comparative review. Brain Res Rev. 1984;8:65–98. doi: 10.1016/0165-0173(84)90018-3. [DOI] [PubMed] [Google Scholar]
- 37.Uylings HBM, Groenewegen HJ, Kolb B. Do rats have a prefrontal cortex. Behavioural Brain Res. 2003;146:3–17. doi: 10.1016/j.bbr.2003.09.028. [DOI] [PubMed] [Google Scholar]
- 38.Sharp T, Zetterström T, Ljungberg T, Ungerstedt U. A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 1987;401:322–30. doi: 10.1016/0006-8993(87)91416-8. [DOI] [PubMed] [Google Scholar]
- 39.Hadar R, Bikovski L, Soto-Montenegro ML, Schimke J, Maier P, Ewing S, et al. Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia. Mol Psychiatry. 2018;23:943–51. doi: 10.1038/mp.2017.52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Weiland A, Wang Y, Wu W, Lan X, Han X, Li Q, et al. Ferroptosis and its role in diverse brain diseases. Mol Neurobiol. 2019;56:4880–93. doi: 10.1007/s12035-018-1403-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Hou WL, Yin J, Alimujiang M, Yu XY, Ai LG, Bao YQ, et al. Inhibition of mitochondrial complex I improves glucose metabolism independently of AMPK activation. J Cell Mol Med. Published online November, 2017. 10.1111/jcmm.13432 [DOI] [PMC free article] [PubMed]
- 42.Fernandez É, Schiappa R, Girault JA, Novère NL. DARPP-32 is a robust integrator of dopamine and glutamate signals. PLoS Comput Biol. 2006;2:e176. doi: 10.1371/journal.pcbi.0020176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Mei L, Nave KA. Neuregulin-ERBB signaling in the nervous system and neuropsychiatric diseases. Neuron. 2014;83:27–49. doi: 10.1016/j.neuron.2014.06.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Rosenstein JM, Krum JM, Ruhrberg C. VEGF in the nervous system. Organogenesis. 2010;6:107–14. doi: 10.4161/org.6.2.11687. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Jeanneteau F, Arango-Lievano M, Chao MV Neurotrophin and synaptogenesis. In: Synapse Development and Maturation. Elsevier; 2020:167-92. 10.1016/B978-0-12-823672-7.00007-7
- 46.Schmidt-Kastner R, Guloksuz S, Kietzmann T, van Os J, Rutten BPF. Analysis of GWAS-derived schizophrenia genes for links to ischemia-hypoxia response of the brain. Front Psychiatry. 2020;11. 10.3389/fpsyt.2020.00393 [DOI] [PMC free article] [PubMed]
- 47.Schmidt-Kastner R, van Os J, Esquivel G, Steinbusch HWM, Rutten BPF. An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol Psychiatry. 2012;17:1194–205. doi: 10.1038/mp.2011.183. [DOI] [PubMed] [Google Scholar]
- 48.Kim S, Hwang Y, Lee D, Webster MJ. Transcriptome sequencing of the choroid plexus in schizophrenia. Transl Psychiatry. 2016;6:e964–e964. doi: 10.1038/tp.2016.229. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Kovács KJ. Invited review c-Fos as a transcription factor: a stressful (re)view from a functional map. Neurochem Int. 1998;33:287–97. doi: 10.1016/S0197-0186(98)00023-0. [DOI] [PubMed] [Google Scholar]
- 50.Holper L, Ben-Shachar D, Mann J. Multivariate meta-analyses of mitochondrial complex I and IV in major depressive disorder, bipolar disorder, schizophrenia, Alzheimer disease, and Parkinson disease. Neuropsychopharmacology. 2019;44:837–49. doi: 10.1038/s41386-018-0090-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Bubber P, Hartounian V, Gibson GE, Blass JP. Abnormalities in the tricarboxylic acid (TCA) cycle in the brains of schizophrenia patients. Eur Neuropsychopharmacol. 2011;21:254–60. doi: 10.1016/j.euroneuro.2010.10.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52.Flatow J, Buckley P, Miller BJ. Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry. 2013;74:400–9. doi: 10.1016/j.biopsych.2013.03.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Zhang J, Wang X, Vikash V, Ye Q, Wu D, Liu Y, et al. ROS and ROS-mediated cellular signaling. Oxid Med Cell Longev. 2016;2016:1–18. doi: 10.1155/2016/4350965. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Hayakawa K, Esposito E, Wang X, Terasaki Y, Liu Y, Xing C, et al. Transfer of mitochondria from astrocytes to neurons after stroke. Nature. 2016;535:551–5. doi: 10.1038/nature18928. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal. 2012;24:981–90. doi: 10.1016/j.cellsig.2012.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Föcking M, Lopez LM, English JA, Dicker P, Wolff A, Brindley E, et al. Proteomic and genomic evidence implicates the postsynaptic density in schizophrenia. Mol Psychiatry. 2015;20:424–32. doi: 10.1038/mp.2014.63. [DOI] [PubMed] [Google Scholar]
- 57.Martins-de-Souza D, Gattaz WF, Schmitt A, Rewerts C, Maccarrone G, Dias-Neto E, et al. Prefrontal cortex shotgun proteome analysis reveals altered calcium homeostasis and immune system imbalance in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2009;259:151–63. doi: 10.1007/s00406-008-0847-2. [DOI] [PubMed] [Google Scholar]
- 58.Das L, Patel B, Patri M. Adolescence benzo[a]pyrene treatment induces learning and memory impairment and anxiolytic like behavioral response altering neuronal morphology of hippocampus in adult male Wistar rats. Toxicol Rep. 2019;6:1104–13. doi: 10.1016/j.toxrep.2019.10.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Mills EL, Kelly B, O’Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol. 2017;18:488–98. doi: 10.1038/ni.3704. [DOI] [PubMed] [Google Scholar]
- 60.López-Armada MJ, Riveiro-Naveira RR, Vaamonde-García C, Valcárcel-Ares MN. Mitochondrial dysfunction and the inflammatory response. Mitochondrion. 2013;13:106–18. doi: 10.1016/j.mito.2013.01.003. [DOI] [PubMed] [Google Scholar]
- 61.Müller N, Weidinger E, Leitner B, Schwarz MJ. The role of inflammation in schizophrenia. Front Neurosci. 2015;9. 10.3389/fnins.2015.00372 [DOI] [PMC free article] [PubMed]
- 62.Szepesi Z, Manouchehrian O, Bachiller S, Deierborg T. Bidirectional microglia–neuron communication in health and disease. Front Cell Neurosci. 2018;12. 10.3389/fncel.2018.00323 [DOI] [PMC free article] [PubMed]
- 63.Menzies RA, Gold PH. The turnover of mitochondria in a variety of tissues of young adult and aged rats. J Biol Chem. 1971;246:2425–9. doi: 10.1016/S0021-9258(18)62305-1. [DOI] [PubMed] [Google Scholar]
- 64.Bergman O, Karry R, Milhem J, Ben-Shachar D. NDUFV2 pseudogene (NDUFV2P1) contributes to mitochondrial complex I deficits in schizophrenia. Mol Psychiatry. 2020;25:805–20. doi: 10.1038/s41380-018-0309-9. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.